XML 62 R52.htm IDEA: XBRL DOCUMENT
v3.23.1

REVENUES - Net Sales from Contracts with Customers by Global Business Unit (Details) - USD ($) $ in Millions | 3 Months Ended
--- | ---
Mar. 31, 2023 | Mar. 31, 2022
Revenue From Contract With Customer [Line Items] |  |
Net sales | $ 3,649 | $ 3,707
U.S. |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 1,734 | 1,757
International |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 1,915 | 1,950
Renal Care |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 892 | 894
Renal Care | U.S. |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 232 | 225
Renal Care | International |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 660 | 669
Medication Delivery |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 687 | 706
Medication Delivery | U.S. |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 436 | 472
Medication Delivery | International |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 251 | 234
Pharmaceuticals |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 523 | 521
Pharmaceuticals | U.S. |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 173 | 157
Pharmaceuticals | International |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 350 | 364
Clinical Nutrition |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 224 | 227
Clinical Nutrition | U.S. |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 78 | 84
Clinical Nutrition | International |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 146 | 143
Advanced Surgery |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 246 | 228
Advanced Surgery | U.S. |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 144 | 136
Advanced Surgery | International |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 102 | 92
Acute Therapies |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 180 | 188
Acute Therapies | U.S. |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 61 | 68
Acute Therapies | International |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 119 | 120
BioPharma Solutions |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 139 | 156
BioPharma Solutions | U.S. |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 69 | 52
BioPharma Solutions | International |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 70 | 104
Patient Support Systems |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 348 | 383
Patient Support Systems | U.S. |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 260 | 295
Patient Support Systems | International |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 88 | 88
Front Line Care |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 302 | 294
Front Line Care | U.S. |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 221 | 207
Front Line Care | International |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 81 | 87
Surgical Solutions |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 81 | 78
Surgical Solutions | U.S. |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 38 | 37
Surgical Solutions | International |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 43 | 41
Other |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 27 | 32
Other | U.S. |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | 22 | 24
Other | International |  |
Revenue From Contract With Customer [Line Items] |  |
Net sales | $ 5 | $ 8

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 924 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=us-gaap_NonUsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_RenalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_MedicationDeliveryMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_PharmaceuticalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_ClinicalNutritionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_AdvancedSurgeryMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_AcuteTherapiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_BioPharmaSolutionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_PatientSupportSystemsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_FrontLineCareMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_SurgicalSolutionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_OtherProductOrServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |